LU DAOPEI Hospital is an Asian bone marrow transplant master and founder is Professor LU DAOPEI, vice president of the Chinese Medical Association. Since its establishment in Beijing in 2001, it has opened a new hospital in Hebei Province in 2017. The hospital specializes in hematology, immune cell therapy and oncology, and has international lymphoma / myeloma centers, pathology and clinical laboratories. As of 2018, more than 70,000 outpatients are treated per year and more than 120,000 inpatients. Linked with various international awards and international insurance companies, the recently opened Beijing boasts the latest facilities and size. 

It has a center, pathology and clinical laboratory. As of 2018, more than 70,000 outpatients are treated per year and more than 120,000 inpatients. Linked with various international awards and international insurance companies, the recently opened Beijing boasts the latest facilities and size. 

Since its inception, it has the largest experience in transplanting blood stem cells in China, with a success rate of more than 99%. In addition, we are treating CIK, DC-CIK, CTL, NK, CMV-CTLs, EBV-CTLs and CAR-T with respect to immune cell treatment and have a very high success rate.

LU DAOPEI Hospital has its own molecular biology and immunology-related laboratories, and is a hospital with high R & D achievements based on various researches and building big data.

LU DAOPEI Hospital has an exclusive partnership with HK HIS and wants to do our best for the treatment of many international patients.